Mountain View, California-based drchrono, which offers a mobile EHR, has raised $2 million from existing investors Runa Capital and Maxfield Capital. This brings the company’s total funding to at least $8.25 million to date.
Other existing investors include Yuri Milner, founder of DST Global, and one of Google’s search quality leaders, Matt Cutts.
“Mobile technology has continued it’s path of disruption across many industries, and healthcare is no exception,” Runa Capital Partner Andre Bliznyuk said in a statement. “Doctors and patients alike have become comfortable handling all sorts of confidential business on their iPads and iPhones, so it’s no surprise that the demand for accessing medical records on mobile has gone through the roof.”
The company’s EHR allows providers to access and input patient medical data directly from Android and iOS mobile devices. The company also has a patient facing app, called onpatient, which allows patients to track medical data and receive health updates from their doctor.
In addition to the funding news, drchrono announced that, in a Black Book survey of more than 30,000 physicians, drchrono was ranked the number one mobile EHR.
Earlier this year, drchrono made patient-facing and provider-facing Apple Watch apps to complement its iPhone and tablet versions. Physicians can use drchrono’s app to view a snapshot of their schedule, see and respond to drchrono chats from colleagues, view and respond to messages from patients, and view patient refill requests as well as lab results. The patient-facing app can help patients send messages directly to their physician, view upcoming appointments, access a list of their medications, and receive medication reminders.
A few months prior, the company updated its iPad-based EHR and smartphone-based PHR so that both can be accessed with Apple’s Touch ID, a security feature that was added to the latest generation of iPads and iPhones.
